<ul><li>Microbot Medical has submitted a 510(k) premarket notification to the FDA for LIBERTY, a single-use robotic system for endovascular procedures.</li><li>The company expects FDA clearance for LIBERTY in the second quarter of 2025.</li><li>LIBERTY aims to redefine the peripheral endovascular space with its single-use, remote-controlled design.</li><li>The system has the potential to lower procedure costs, increase efficiency, and improve patient care.</li></ul>

Microbot Medical submits LIBERTY surgical robot to FDA for approval

Discover more